The Metabolic Syndrome at the Beginning of the XXI Century. A Genetic and Molecular Approach

Content: 
Copyright, Page ii
List of Authors, Pages iii-v
Introduction, Pages 1-2, M. Serrano Ríos, J.F. Caro, R. Carraro, J.A. Gutiérrez Fuentes
1 - Origin and Development of the Metabolic Syndrome, Pages 5-13, Gaetano Crepaldi
2 - Intracellular Signaling Mechanisms Involved in Insulin Action, Pages 15-42, Antonio Zorzano
3 - Cellular Models for the Study of Type 2 Diabetes, Pages 43-65, Margarita Lorenzo, Ángela M. Valverde, Manuel Benito
4 - Transgenic Animal Models and the Metabolic Syndrome, Pages 67-82, Sylvie Franckhauser, Fátima Bosch
5 - Aging and the Metabolic Syndrome, Pages 83-99, Antonio Ruiz-Torres
6 - Gene/Environment Interaction: Thrifty Genotype Versus Thrifty Phenotype, Pages 101-108, Peter M. Nilsson
7 - Epidemiology of the Metabolic Syndrome, Pages 109-129, Carlos Lorenzo, Manuel Serrano Ríos
8 - Genetic Susceptibility to the Metabolic Syndrome, Pages 133-151, Valeriya Lyssenko, Leif Groop
9 - Genomic of Skeletal Muscle and its Implications in the Metabolic Syndrome, Pages 153-161, Sophie Rome, Hubert Vidal
10 - The Metabolic Syndrome: Obesity and Diet Modulates the Expression of its Genetic Predisposition, Pages 163-175, José M. Ordovás, Dolores Corella
11 - Pathophysiology of Insulin Action in Humans, Pages 179-197, Stefano Del Prato
12 - Leptin, Insulin and Blood-Brain Barrier Relations in Obesity, Pages 199-215, William A. Banks, Naoko Nonaka, Seiji Shioda, Ryota Nakaoke, John E. Morley
13 - Chronic Inflammatory Hypothesis in the Metabolic Syndrome, Pages 217-231, José-Manuel Fernández-Real, Wifredo Ricart
14 - Metabolic Syndrome and Adipokines, Pages 233-251, Toshimasa Yamauchi, Takashi Kadowaki
15 - Role of PPARs in the Pathogenesis of the Metabolic Syndrome, Pages 253-269, Gema Medina-Gómez, Sarah Gray, Antonio Vidal-Puig
16 - The Lipotoxicity and Glucotoxicity Hypothesis in the Metabolic Syndrome and Type 2 Diabetes, Pages 271-282, George Dimitriadis, Eleni Boutati, Sotirios A. Raptis
17 - Thermogenesis and the Metabolic Syndrome, Pages 283-303, María Luisa Bonet, Catalina Picó, Andreu Palou
18 - Nitric Oxide and Cell Metabolism Dysfunction in the Metabolic Syndrome, Pages 305-318, Enzo Nisoli, Salvador Moncada
19 - Endothelial Dysfunction in the Metabolic Syndrome, Pages 321-338, Angelo Avogaro
20 - Hypertension in the Metabolic Syndrome, Pages 339-346, Andrea Natali, Ele Ferrannini
21 - Dyslipidemia in the Metabolic Syndrome, Pages 347-358, Markolf Hanefeld, Frank Schaper
22 - Alterations in Thrombosis and Fibrinolysis in the Metabolic Syndrome, Pages 359-368, Juan F. Viles-González, Brian G. Choi, Juan J. Badimón
23 - Insulin Resistance and Coronary Heart Disease, Pages 369-382, Markku Laakso, Johanna Kuusisto
24 - Nonalcoholic Fatty Liver Disease: A new entry in the Metabolic Syndrome?, Pages 383-392, Norbert Stefan, Hans-Ulrich Häring
25 - Hyperinsulinism, Insulin Resistance and Fertility, Pages 393-412, Juan José Espinós Gómez, Joaquim Calaf i Alsina
26 - Nutritional Treatment in the Metabolic Syndrome, Pages 415-430, Miguel A. Rubio, María D. Ballesteros Pomar, Carmen Moreno
27 - Drug Treatment in the Metabolic Syndrome, Pages 431-461, Sotirios K. Karathanasis, Rick J. Schiebinger
28 - The Metabolic Syndrome: Lifestyle, Drugs, or Both?, Pages 463-474, Adrian Cameron, Jonathan Shaw, Paul Zimmet
Index, Pages 475-479